Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. - Wikidata - wikimedia - TriplyDB

Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.

Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.

http://www.wikidata.org/entity/Q46533885

about

Stem Cells and Progenitor Cells for Tissue-Engineered Solutions to Congenital Heart Defects Stem cell therapy and tissue engineering for correction of congenital heart disease Bioengineering and the cardiovascular system Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and application Cardiovascular tissue engineering: where we come from and where are we now?Smooth muscle and other cell sources for human blood vessel engineering Tissue engineering in the vasculature Scaffolds in vascular regeneration: current status Stem cell sources for vascular tissue engineering and regeneration Matrix production and organization by endothelial colony forming cells in mechanically strained engineered tissue constructs Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae Clinical translation of controlled protein delivery systems for tissue engineering Long-term results of cell-free biodegradable scaffolds for in situ tissue-engineering vasculature: in a canine inferior vena cava model The Tissue-Engineered Vascular Graft-Past, Present, and Future.Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.Construction of tissue-engineered small-diameter vascular grafts in fibrin scaffolds in 30 days Development of Small-Diameter Vascular Grafts Based on Silk Fibroin Fibers from Bombyx mori for Vascular Regeneration.Biomaterials for vascular tissue engineering Inspiration and application in the evolution of biomaterials.In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model.Preparation of decellularized and crosslinked artery patch for vascular tissue-engineering application.Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials.Blood vessel-derived acellular matrix for vascular graft application Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.Cell-seeding techniques in vascular tissue engineering Tissue-engineered vascular grafts: does cell seeding matter?Implantation of inferior vena cava interposition graft in mouse model Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective.The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructs Hydrostatic pressure independently increases elastin and collagen co-expression in small-diameter engineered arterial constructs.Comparison of a closed system to a standard open technique for preparing tissue-engineered vascular grafts Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel Artificial niche combining elastomeric substrate and platelets guides vascular differentiation of bone marrow mononuclear cells.Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method Development of small diameter nanofiber tissue engineered arterial grafts.Tissue engineering of blood vessel.Challenges in translating vascular tissue engineering to the pediatric clinic.A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts.Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI The innate immune system contributes to tissue-engineered vascular graft performance.

P2860

Q26785527-779BF969-3940-402B-A95C-E0BCA30F5D29 Q26801514-2784221D-1238-4E04-B195-0D18ED6FEBF4 Q26827097-FF9DABD5-FA5F-4A9E-B008-26970C184E51 Q26853054-09158222-6A75-4739-84CB-41CB67D82213 Q26853338-C5C1E575-69F9-48B4-A07A-2656BCB9CC18 Q26862581-5C5299F3-BF72-4EE8-8D9C-27F2377F9DC6 Q26999017-651E4DF0-6C8C-4AA0-86A5-7E6811B00472 Q27012628-404224FF-9E61-407E-AE74-CD96B6A2EBD4 Q27028106-98436751-6F89-486A-92C8-9E749C260989 Q27308049-9E2FB240-AC5E-46E0-9F47-D0C6EF475115 Q27321144-98B78F86-543E-4EE0-97F6-1771C0F017D5 Q28084738-FCEA973B-99EB-483A-88E7-A46CC4B24521 Q28482423-431D8E78-77DF-467D-B681-DC70C940E740 Q30385854-54FE889A-0B56-447C-8950-AB0196330FAB Q33537670-A6ECB61D-E3EA-437E-8028-753041C0B0FA Q33571735-22E3C6C7-4550-4E95-9618-C186B5CD79D4 Q33608288-97EFBBD1-47E4-4572-B022-82C7F51389E9 Q33655808-BED7BDCA-15E6-4E41-A551-E850722B8620 Q33765529-782D3B8F-6367-4722-976B-05274DD40C1D Q33822574-0B991156-7DFF-439B-A754-5D780657B7F3 Q33884441-CACF7AA7-8B51-4A38-8D66-4F21F6049308 Q33994263-D604B804-B7DB-4876-8976-8BDDE022D8CB Q34014438-E4E4BC85-46C5-4734-B938-CD069C83071F Q34146262-A14F3771-8DFF-4BF6-860C-D28E22AAFD94 Q34160631-2CD64F70-41FD-4327-9985-FA95F2228237 Q34271210-4BB5A325-1024-4E88-A710-699CC8D5310D Q34293482-E00CFBBA-F285-45C0-8A41-6F89C8D7DB98 Q34306425-45BFC170-DA5D-45F3-AC01-AC806501D158 Q34535812-706B822A-7B22-49C0-B417-6E38FABABF91 Q34598385-98B50B16-F076-48AE-BA0A-7F9A57979C12 Q34920180-BA7855D5-9358-41CB-996F-433F6D9D6768 Q35105356-D65F565A-80F5-4B49-BDD3-CBAA5388B12B Q35125074-4BDDF614-7224-4030-86B2-20AF311813C5 Q35239498-175A54AA-4686-4CD3-9F22-AF8830E9FEB9 Q35242269-11B473C1-1D68-4BFE-B07A-C74F9B062D72 Q35459503-AF1904E5-CECA-40D3-ABB2-146491F36CB8 Q35486978-C4356713-95A4-4C1D-8E56-7831F97937A8 Q35609601-06086813-966D-433B-B279-9BCF26B735D7 Q35609635-AAF9598A-641E-4906-8F73-F40060712C4B Q35660078-A80B6DBD-2272-4384-A526-AC5B2A4DCBC5

P2860

Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.

http://www.wikidata.org/entity/Q46533885

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Midterm clinical result of tis ...... autologous bone marrow cells.

@en

Midterm clinical result of tis ...... autologous bone marrow cells.

@nl

type

label

Midterm clinical result of tis ...... autologous bone marrow cells.

@en

Midterm clinical result of tis ...... autologous bone marrow cells.

@nl

prefLabel

Midterm clinical result of tis ...... autologous bone marrow cells.

@en

Midterm clinical result of tis ...... autologous bone marrow cells.

@nl

P1433

Q46533885-2E89C1D1-E60A-4AA3-BF79-53FE19BC938A

P1476

Q46533885-ED6C2A54-F1B9-4C24-90A8-1958A725BE4A

P2093

Q46533885-041AABFD-9087-48A1-A926-D29D980F23B7

Q46533885-17921BA3-3153-4CFA-B317-9533ACCF56DB

Q46533885-18E4B168-43BB-4167-A991-9F2D696179EF

Q46533885-2AE3E30C-8B94-4C12-9371-DD06AC898C05

Q46533885-4ECD7BFD-4C9F-431F-BA5A-7C072A4F78B4

Q46533885-6EDE8034-94C2-4725-A3ED-4DE466F7D6C2

Q46533885-77EFA1D4-896E-4952-88EE-C0780BC661B7

Q46533885-993FF37F-9A23-4CD2-AB31-4BAB1BE04528

Q46533885-FFEEC7D0-D6EE-41FF-BE4A-5A8A100F5F54

P304

Q46533885-6DAA3A56-7C15-4536-A26E-8A3286C13C09

P31

Q46533885-2CDAF710-69A4-473C-9234-039C2353F6BD

P356

Q46533885-25E9DFF9-ED9C-460C-A728-8BB277C9DB4B

P407

Q46533885-4CC67B45-F225-4CCB-98B5-E14F75061D38

P433

Q46533885-63D68F90-1EEB-4E7F-9421-5F487F18F278

P478

Q46533885-C99D3490-D858-405E-80BB-7A0711928447

P577

Q46533885-678991F3-6025-49B7-A30E-C81FFD81F14C

P5875

Q46533885-B1D79B7A-2620-479A-94D5-950695763F67

P698

Q46533885-A4092D2D-48E9-4054-BBF1-55850674754C

P921

Q46533885-2AB3ED10-CC41-454F-AE5E-BB0B2156B302

P356

J.JTCVS.2004.12.047

P1433

The Journal of Thoracic and Cardiovascular Surgery

P1476

Midterm clinical result of tis ...... autologous bone marrow cells.

@en

P2093

Goki Matsumura

http://www.w3.org/2001/XMLSchema#string

Hiromi Kurosawa

http://www.w3.org/2001/XMLSchema#string

Manabu Watanabe

http://www.w3.org/2001/XMLSchema#string

Masayoshi Nagatsu

http://www.w3.org/2001/XMLSchema#string

Narutoshi Hibino

http://www.w3.org/2001/XMLSchema#string

Takahiko Sakamoto

http://www.w3.org/2001/XMLSchema#string

Takeshi Konuma

http://www.w3.org/2001/XMLSchema#string

Toshiharu Shin'oka

http://www.w3.org/2001/XMLSchema#string

Yuji Naito

http://www.w3.org/2001/XMLSchema#string

P304

1330-1338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JTCVS.2004.12.047

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7798950

http://www.w3.org/2001/XMLSchema#string

P698

15942574

http://www.w3.org/2001/XMLSchema#string

P921